The reconstructed pathway does not recreate a bladder reservoir or a normal outlet controlled by the patient. Urine therefore moves from the ureters through the intestinal segment and exits at the abdominal stoma as it is produced. This noncontinent design makes an external collection pouch necessary for ongoing drainage.
Each component performs a separate function. The isolated ileal segment serves as the conduit, the ureters deliver urine from the upper urinary tract into that segment, and the stoma provides the external exit through the abdominal wall. Together, these structures replace the bladder’s pathway without restoring native urinary storage.
An ileal conduit prioritizes dependable drainage rather than continence or voluntary emptying. Because urine leaves continuously through the stoma, management centers on pouch collection and protection of the surrounding skin. This differs from reconstructions designed to hold urine temporarily, although the appropriate choice depends on bladder function and the clinical situation.
The procedure requires isolating a short portion of the small intestine, connecting the ureters to that segment, and bringing the segment to the abdominal surface as a stoma. The resulting pathway directs urine away from the bladder region and into an external pouch, establishing noncontinent drainage.
The approach is commonly considered after radical cystectomy for bladder cancer, when removal of the bladder eliminates normal urine storage and outflow. It may also be selected for severe bladder dysfunction when the native bladder cannot function normally. In these settings, the conduit offers a reliable reconstructive option.
Long-term management includes maintaining the external collection pouch and caring for the abdominal stoma and nearby skin. Since drainage is continuous rather than voluntarily controlled, pouch management and skin protection remain central to daily care. These requirements reflect the conduit’s noncontinent design and its role as a permanent urine exit pathway.